FDA approves Keytruda in cervical cancerMerck & Co’s blockbuster Keytruda has been approved in advanced second line cervical cancer, becoming the first drug Share XFDA approves Keytruda in cervical cancerhttps://pharmaphorum.com/news/fda-approves-keytruda-cervical-cancer/
